RemovedRisk Factors
Any inquiry into the regulatory status of our cosmetics and any related interruption in the marketing and sale of these products could damage our reputation and image in the marketplace.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedRisk Factors
on commercially reasonable terms, or at all, or we may need to redesign or rebrand our marketing strategies or products, which may not be possible.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RewordedRisk Factors
For example, US and global markets have been experiencing experienced volatility and disruption due to interest rate and inflation increases, such as higher inflation rates in the United States, which increased in the second half of 2021 and have remained above the Federal Reserve’s inflation target, as well as the continued escalation of geopolitical tensions, tensions and conflict, including those as a result of resulting from the conflicts between Russia and Ukraine and war in Iran, the broader conflict in the Middle East. East and Russia's invasion of Ukraine.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
Trade restrictions implemented by the United States, China, Canada, the UK, United Kingdom (the “UK”), the European Union (the “EU”) or any of the other jurisdictions in which we conduct significant business in connection with a global trade war could result in us raising may affect our suppliers’ ability to source products efficiently or create other supply chain disruptions, impacting the prices further or making changes to of and supply of our operations, any of which could result in a material adverse effect on our financial condition and results of operations. products.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
As a company engaged in distribution on a global scale, our operations, including those of our third-party manufacturers, suppliers, brokers and delivery service providers, are subject to the risks inherent in such activities, including industrial accidents, environmental events, strikes and other labor disputes (such as the recent port strike), strikes in 2024), disruptions or delays in shipments, shipments (including delays at international and domestic ports), disruptions in information systems, product quality control, safety, licensing requirements and other regulatory issues, costs (including customs duties, quotas and tariffs), as well as weather events and natural disasters (such as the January 2025 Southern California wildfires and the 2024 Atlantic hurricanes), disasters, pandemics (such as the coronavirus pandemic), border disputes, international conflict (such as the ongoing military war in Iran, the broader conflict in Ukraine and the Middle East), East and Russia's invasion of Ukraine), acts of terrorism and other external factors over which we and our third-party manufacturers, suppliers, brokers and delivery service providers have no control.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
The potential effects of these laws states’ legislation are potentially significant far-reaching and may require us to modify our data collection or processing practices and policies and to incur substantial costs and expenses in an effort to comply, and increase our potential exposure it is unclear whether, and if so how, the US Congress will respond to regulatory enforcement and/or litigation. these overlapping, state-by-state enactments.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
Nonetheless, as As a result of the additional US tariffs announced since early 2025 as well as inflation, on August 1, 2025, the Company will raise we raised prices globally for all products sold, which could result in the loss of consumers and materially and adversely affect our business, financial condition and results of operations. sold.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, all the shares of common stock subject to stock options and restricted stock units and shares of restricted stock awards outstanding and reserved under our 2014 Equity Incentive Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan have been registered on Form S-8 under the Securities Act and such shares, once the underlying equity award vests, will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, all the shares of common stock subject to stock options and restricted stock units and shares of restricted stock awards outstanding and reserved under our 2014 Equity Incentive Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan have been registered on Form S-8 under the Securities Act and such shares, once the underlying equity award vests, will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
The substantial up-front investment required, the lack of consumer awareness of our products in jurisdictions outside of the United States, differences in consumer preferences and trends between the United States and other jurisdictions, the risk of inadequate intellectual property protections and differences in packaging, labeling and related laws, rules and regulations are all substantial matters that need to be evaluated prior to doing business in new territories.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
While the majority of the substantive requirements will only not apply two years later, until the second half of 2026 (subject to proposed amendments to delay their implementation under the EU Digital Omnibus on AI Regulation Proposal), certain of its the EU AI Act’s provisions regarding prohibited AI systems and AI literacy obligations are already applicable.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
For example, in In connection with our acquisition of Naturium, rhode, we paid total cash consideration of approximately $333 $590.1 million using the proceeds from an incremental term loan under our existing credit facility, borrowings on our existing revolving facility, and cash on the balance sheet and sheet, as well as approximately $58 $300.3 million of our stock. stock, and a potential earnout initially valued at $7.1 million.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, if we are found to infringe, misappropriate, dilute or otherwise violate third-party trademark, patent, copyright or other proprietary rights, our ability to use brands to the fullest extent we plan may be limited, we may need to obtain a license, which may not be available on commercially reasonable terms, or at all, or we may need to redesign or rebrand our marketing strategies or products, which may be expensive or may not be possible.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedRisk Factors
We cannot predict whether these policies will continue or if new policies will be enacted; however, we uncertainty regarding these policy changes in trade regulation or additional incremental tariffs or counter-tariffs could experience have a material adverse effect on our business, financial condition and results of operations if these or other incremental tariffs go into effect. operations.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
We have made certain assumptions relating to our potential acquisition of rhode that may prove to be inaccurate, including as the result of the failure to realize the expected benefits of the acquisition, failure to realize expected revenue growth rates and higher than expected operating, transaction and integration costs, as well as general economic and business conditions that adversely affect rhode.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
Unless otherwise stated, the following discussion and analysis are for the fiscal year ended March 31, 2026, compared to the fiscal year ended March 31, 2025. Discussion and analysis for the fiscal year ended March 31, 2025 compared to the year ended March 31, 2024 may be found in the section titled “Management’s discussion and analysis of financial condition and results of operations” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, filed with the SEC on May 29, 2025.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
On July 31, 2025, the US administration issued a formal Executive Order modifying the reciprocal tariff regime under the IEEPA. However, in February 2026, the Supreme Court of the United States ruled that the IEEPA does not authorize the US administration to impose tariffs, and the tariffs paid by importers under the Executive Order are subject to refund. We are evaluating the impact of the Supreme Court ruling and the subsequent order issued by the CIT, and are monitoring related developments from the CBP regarding its plan to process refunds to importers of record, including the launch on April 20, 2026 of the CBP's Consolidated Administration and Processing of Entries (“CAPE”) system for submitting refund claims, as well as the administration’s decision on whether or not to appeal the CIT’s order. Effective February 24, 2026, the US administration has imposed a 10% global tariff under Section 122 of the Trade Act of 1974 that could remain in place for up to 150 days, and may, by legislative action, be extended. Multiple legal challenges to the Section 122 tariffs have been filed, and on May 7, 2026, the U.S. Court of International Trade ruled that the Section 122 tariffs are unlawful; however, the court's injunction applies only to the named plaintiffs, and the tariffs remain in effect for all other importers pending appeal. During the fiscal year 2026, the Company paid approximately $58.5 million of IEEPA Tariffs. These tariffs, as well as a government’s adoption of “buy national” and similar policies or retaliation by another government against such tariffs or policies, could introduce significant uncertainty into the market and may affect the prices of and supply of the products available to us. Tariffs also can impact our or our suppliers’ ability to source products efficiently or create other supply chain disruptions. We may not be able to fully or substantially mitigate the impact of these or future tariffs, pass price increases on to our customers or secure adequate alternative sources of products or materials for our products, which would have a material adverse effect on our business, financial condition and results of operations.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
On August 5, 2025, we consummated the acquisition (the “rhode Acquisition”) of HRBeauty LLC (“rhode”), the fast-growing, multi-category lifestyle beauty brand founded by Hailey Bieber for a purchase price of $897.5 million in a combination of cash, shares of our common stock, and potential earnout. See Note 3, “Acquisitions,” in the Notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
In connection with the rhode Acquisition, we recorded a liability at fair value for the contingent consideration potentially payable to the sellers of rhode subject to achievement of certain earnout thresholds, with a maximum payment of $200.0 million. We expect to pay (if due and owing) annually within four months after each measurement period ending September 30, 2026, 2027, and 2028. The fair value of the liability is calculated using Monte Carlo simulation based on corresponding projected revenue. We evaluate the fair value of the contingent consideration each reporting period and adjust the carrying value as new information becomes available. See Note 3, “Acquisitions,” and Note 7, “Fair value of financial instruments,” in the Notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
In connection with the rhode Acquisition, the Company recorded a fair value adjustment of $57.6 million for the fiscal year ended March 31, 2026, driven by the outperformance of rhode's revenue results relative to the earnout thresholds set forth in the merger agreement entered into in connection with the rhode Acquisition.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
March 31, 2025. Working capital, excluding cash and debt, was $193.5 million and $214.8 million as of March 31, 2026 and March 31, 2025, respectively.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
On August 5, 2025, we entered into the Fifth Amendment. The Fifth Amendment, among other things, established the Term Facility, made customary changes in connection with adding a term loan facility, increased the maximum permitted consolidated total net leverage ratio financial covenant, increased the interest rate margin for loans under our existing Revolving Credit Facility and increased the unused line fee under our existing Revolving Credit Facility. The proceeds of the Term Facility were made available to e.l.f. Cosmetics and certain of our other subsidiaries to pay a portion of the consideration for the rhode Acquisition. The maturity date of the Term Facility is March 3, 2030.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
Unused commitments under our existing Revolving Credit Facility are subject to a fee, to be determined based on consolidated total net leverage ratio levels, ranging from 0.15% to 0.25%.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
AddedMD&A
In connection with the rhode Acquisition, we recorded a liability at fair value for the contingent consideration potentially payable to the sellers of rhode subject to achievement of certain earnout thresholds, with a maximum payment of $200.0 million. We expect to pay (if due and owing) annually within four months after each measurement period ending September 30, 2026, 2027, and 2028. The fair value of the liability is estimated using discounted future cash flows based on a Monte Carlo simulation methodology using significant level 3 inputs such as forecasts of revenue. We evaluate the fair value of the contingent consideration each reporting period and adjust the carrying value as new information becomes available. See Note 3, “Acquisitions,” and Note 7, “Fair value of financial instruments,” in the Notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RemovedMD&A
The US tariff policies are continuing to evolve. As a result, our risks and mitigation plans will also continue to evolve as further developments arise. Any alteration of trade agreements and terms between China and the United States, including limiting trade with China, imposing additional tariffs on imports from China and potentially imposing other restrictions on imports from China to the United States may result in further or higher tariffs or retaliatory trade measures by China. We are in the process of determining our incremental tariff cost exposure in light of continuing changes to tariff policies, and the full extent of our potential mitigation plans, as well as the associated timing to implement such plans. To mitigate our risk of ongoing exposure to tariffs, the Company will raise prices globally for all products sold. The Company may also seek to shift production outside of China into regions where we expect tariffs to be lower and to source the same products in more than one region, to the extent it is possible and not cost-prohibitive.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
On May 28, 2025, the Company entered into a definitive agreement to acquire rhode, a fast-growing, multi-category lifestyle beauty brand founded by Hailey Bieber and known for its collection of high-performance, skin-focused products. The deal is comprised of $800.0 million at closing, subject to customary adjustments, in a combination of $600.0 million of cash and $200.0 million of stock, and potential earnout consideration of up to $200.0 million based on the future growth of the brand over a three-year timeframe. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the second quarter of Fiscal 2026. The transaction will be accounted for as a business combination using the acquisition method of accounting, which requires certain assets acquired and liabilities assumed to be recognized at fair
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
value as of the acquisition date. As of the date of this filing, the Company is currently evaluating the preliminary allocation of the purchase price to the net assets acquired and liabilities that will be assumed in the transaction.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
We recorded an impairment charge on one of our investments of $2.9 million during the fiscal year ended March 31, 2024, as an identified event or change in circumstances resulted in an indicator of impairment. We did not record an impairment charge on our investment during the fiscal year ended March 31, 2025 as any identified events or changes in circumstances did not result in an indicator of impairment during that period.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
Impairment of equity investment was $2.9 million in the fiscal year ended March 31, 2024. We elected the measurement alternative for equity investments that do not have readily determinable fair values. We recorded an impairment charge on one of our investments of $2.9 million during the fiscal year ended March 31, 2024, as an identified event or change in circumstances resulted in an indicator of impairment. We did not record an impairment charge on our investment during the fiscal year ended March 31, 2023 as any identified events or changes in circumstances did not result in an indicator of impairment during that period.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility was collateralized by substantially all of the Company’s assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on Company’s consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provided for sub-facilities in the form of a $7 million letter of credit and a $5 million swing line loan.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bore interest, at the borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the United States (“US”) dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio (the “Applicable Margin”) or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, the Company amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR plus 0.10% subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RemovedMD&A
Aggregate future minimum principal payments are $256.7 million due March 31, 2030.
Read it in 10-K May 29, 2025 at sec.govopen_in_new
RewordedMD&A
SOFR (subject to a 0.00% floor) or an alternate base rate (subject to a 1.00% floor) as set forth in the Fourth Fifth Amendment, plus an interest rate margin, to be determined based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.125% 1.50% to 1.875%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, 2.25%, and (ii) in the case of alternate base rate loans, 0.125% 0.50% to 0.875%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. 1.25%.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in net working capital was primarily driven by a $2.7 million increase in accounts receivable, a $75.9 $67.4 million increase in prepaid and other assets, assets and $17.5 million increase in accounts receivable, partially offset by a $7.9 $75.3 million decrease in other liabilities, and a $23.4 million decrease increase of accounts payable and accrued expenses, partially offset by expenses and a $4.9 $7.3 million decrease in inventory inventory.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
The increase on a dollar basis was primarily related to increased marketing marketing, merchandising and digital spend distribution costs of $130.0 $129.1 million, increased compensation and benefits expense of $32.9 million, increased operations costs of $26.4 million, increased retail fixturing and visual merchandising costs of $21.1 $55.1 million, increased depreciation and amortization of $12.2 million and $35.0 million, increased professional fees of $11.5 $20.6 million, and increased regulatory fees of $8.6 million.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
The Company We used the Incremental Term Loan Loan, together with cash from its our balance sheet and additional borrowings under our Amended Revolving Credit Facility Facility, to consummate the Acquisition acquisition of Naturium (as defined in Note 3 hereto) 3, “Acquisitions,” in the Notes to our unaudited condensed consolidated financial statements included elsewhere in this Annual Report on Form 10-K) and to pay related fees and expenses in connection with the Acquisition acquisition of Naturium and Second Amendment.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
This For the fiscal year ended March 31, 2026, net cash provided by financing activities was offset $533.9 million and was primarily driven by proceeds from long term debt of $256.7 $600.0 million, proceeds from the revolving line of credit of $50.0 million and cash received from the exercise of stock options of $1.0 $5.8 million.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
“Exhibits, While our significant accounting policies are more fully described in Note 2, “Summary of significant accounting policies,” in the Notes to our consolidated financial statement schedules,” statements included elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies and estimates are critical to our business operations and understanding of our financial results.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
See the risk factor titled “Additional “Changes in the US tariffs or other and international trade policies, including tariffs, trade restrictions placed on imports, and retaliatory trade measures taken by other countries and resulting trade wars may have a material adverse impact on the Company’s financial condition and results of operations” included as part of Item 1A. our business,
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
Interest expense increased $6.8 $21.5 million, or 97%, to $35.3 million in the fiscal year ended March 31, 2026, as compared to $13.8 million in the fiscal year ended March 31, 2025, as compared to $7.0 million in the fiscal year ended March 31, 2024. 2025.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
Fiscal year ended March 31, (percentage of net sales) 2026 2025 2024 2023 Net sales 100% 100% 100% Cost of sales 29% 29% 33% 29% Gross profit 71% 71% 67% 71% Selling, general and administrative expenses 63% 59% 56% 56% Change in fair value of contingent consideration 4% —% —% Operating income 4% 12% 15% 12% Other income (expense), income, net —% —% —% Impairment of equity investment —% —% —% Interest expense, net (2)% (1)% (1)% —% Loss on extinguishment of debt —% —% —% Income before provision for income taxes 2% 11% 14% 11% Income tax provision (1)% (3)% (1)% —% Net income 2% 9% 12% 11%
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
The change in the income tax provision was primarily driven by an increase a decrease in income before the provision for income taxes of $76.9 million, partially offset by an increase in discrete tax benefits of $14.4 million, primarily related to stock-based compensation. $105.0 million.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
Gross profit increased $211.6 $221.7 million, or 29%, 24%, to $1,157.3 million in the fiscal year ended March 31, 2026, compared to $935.7 million in the fiscal year ended March 31, 2025, compared to $724.1 million in the fiscal year ended March 31, 2024. 2025.
Read it in 10-K May 21, 2026 at sec.govopen_in_new
RewordedMD&A
For the fiscal year ended March 31, 2025, net cash used in financing activities This was $74.4 million and was primarily driven offset by the repayment of previous Revolving Credit line of $89.5 $50.0 million, repurchases of our common stock of $67.1 $50.0 million, repayments on the Amended Term Loan Facility of $173.4 $15.0 million and payment of debt issuance costs of $2.1 $6.9 million associated with the new Revolving Credit Facility.
Read it in 10-K May 21, 2026 at sec.govopen_in_new